ALPS Advisors’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-52,950
| Closed | -$1.19M | – | 1048 |
|
|
2022
Q3 | $1.19M | Sell |
52,950
-4,370
| -8% | -$98K | 0.01% | 414 |
|
|
2022
Q2 | $1.42M | Buy |
+57,320
| New | +$1.42M | 0.01% | 376 |
|
|
2021
Q2 | – | Sell |
-130,688
| Closed | -$10.8M | – | 909 |
|
|
2021
Q1 | $10.8M | Buy |
130,688
+6,320
| +5% | +$521K | 0.11% | 142 |
|
|
2020
Q4 | $11.3M | Buy |
124,368
+13,621
| +12% | +$1.24M | 0.13% | 140 |
|
|
2020
Q3 | $4.43M | Buy |
110,747
+4,768
| +4% | +$191K | 0.07% | 167 |
|
|
2020
Q2 | $3.64M | Sell |
105,979
-31,454
| -23% | -$1.08M | 0.05% | 179 |
|
|
2020
Q1 | $3.05M | Sell |
137,433
-14,724
| -10% | -$327K | 0.05% | 178 |
|
|
2019
Q4 | $2.98M | Buy |
152,157
+21,771
| +17% | +$426K | 0.02% | 195 |
|
|
2019
Q3 | $2.03M | Sell |
130,386
-6,048
| -4% | -$93.9K | 0.02% | 209 |
|
|
2019
Q2 | $2.77M | Sell |
136,434
-19,404
| -12% | -$394K | 0.02% | 197 |
|
|
2019
Q1 | $2.74M | Buy |
155,838
+6,735
| +5% | +$118K | 0.02% | 196 |
|
|
2018
Q4 | $1.91M | Buy |
149,103
+54,571
| +58% | +$700K | 0.01% | 224 |
|
|
2018
Q3 | $1.54M | Buy |
94,532
+17,818
| +23% | +$290K | 0.01% | 288 |
|
|
2018
Q2 | $870K | Buy |
+76,714
| New | +$870K | 0.01% | 364 |
|